Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 2

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 15
Chunk 2
---
 10.2
     
    06/20/2014

    10.3*
     
    Form of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice
     
    10-Q

    10.2
     
    11/01/2023

    10.4*
     
    2014 Employee Stock Purchase Plan
     
    S-1/A

    10.8
     
    07/10/2014

    10.5*
     
    Atara Biotherapeutics, Inc. Third Amended and Restated 2018 Inducement Plan
     
    S-8

    4.3
     
    07/22/2022

    10.6*
     
    Form of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice under the Inducement Plan
     
    10-Q

    10.2
     
    11/07/2019

    10.7*
     
    Form of Stock Option Agreement and Stock Option Grant Notice under the Inducement Plan
     
    10-Q

    10.3
     
    05/08/2018

    10.8*
     
    Forms of Inducement Grant Notice and Inducement Grant Agreement
     
    10-Q

    10.3
     
    08/07/2017

    10.9*
     
    Form of Indemnification Agreement made by and between Atara Biotherapeutics, Inc. and each of its directors and executive officers
     
    S-1

    10.9
     
    06/20/2014

    10.10*
     
    Form of Atara Biotherapeutics, Inc. Executive Employment Agreement
     
    10-K

    10.39
     
    02/28/2022

    10.11*
     
    Executive Employment Agreement, dated May 23, 2019, by and between Pascal Touchon and Atara Biotherapeutics, Inc.
     
    8-K

    10.1
     
    05/28/2019

    10.12†
     
    Exclusive License Agreement, by and between Atara Biotherapeutics, Inc. and Memorial Sloan Kettering Cancer Center, dated as of June 12, 2015
     
    S-1

    10